Skip to main content
Synthomer PLC logo

Synthomer PLC — Investor Relations & Filings

Ticker · SYNT ISIN · GB00BNTVWJ75 LEI · 213800EHT3TI1KPQQJ56 IL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2019-07-30 Director's Dealing
Country GB United Kingdom
Listing IL SYNT

About Synthomer PLC

https://www.synthomer.com/

Synthomer PLC is a specialty chemical company that develops, manufactures, and markets high-performance, specialized polymers and ingredients. The company's portfolio is centered on aqueous polymers, which are critical components for various industries, including coatings, construction, adhesives, textiles, and health and protection. These products are used in applications such as paints, mortars, sealants, pressure-sensitive adhesives, and as binders for textiles. Synthomer is also a leading global supplier of water-based polymers for the medical glove market, focusing on delivering innovative and sustainable solutions to its customers worldwide.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the RNS Number (2241H) and explicitly states it is providing information under Article 19(3) of the Market Abuse Regulation regarding 'Director / PDMR Shareholding'. It details a transaction (Take up of Rights in relation to a Rights Issue) made by a Director/PDMR (Brendan Connolly). This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content mandates the DIRS classification over the general RNS fallback.
2019-07-30 English
Director/PDMR Shareholding
Share Issue/Capital Change Classification · 1% confidence The document is an official notification identified by the 'RNS Number' and explicitly states it is providing 'Director / PDMR Shareholding' information in accordance with the Market Abuse Regulation. It details a transaction (take up of Rights in a Rights Issue) by a person closely associated with the Chief Financial Officer (a PDMR). This directly corresponds to the definition of Director's Dealing (insider trades). The presence of the RNS header and the nature of the content confirm this is a specific regulatory disclosure, not a general announcement of a report.
2019-07-30 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details transactions made by a Director/PDMR (Chief Financial Officer, Stephen Bennett) involving the acquisition of shares related to a Rights Issue. This type of filing, reporting personal share transactions by company directors, directly corresponds to the 'Director's Dealing' category. Although it is distributed via RNS, the specific content dictates the classification should be DIRS, as DIRS is more specific than the general RNS fallback.
2019-07-30 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is identified by the 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details transactions made by a Director/PDMR (Chief Executive Officer) regarding the take-up of Rights under a Rights Issue. This falls directly under the definition of insider trading or executive share transactions, which corresponds to the 'Director's Dealing' category (DIRS). Although it is an RNS announcement, the specific nature of the content (Director/PDMR Shareholding) makes DIRS a more precise classification than the general RNS fallback.
2019-07-30 English
Results of Rump Placing
Regulatory Filings Classification · 1% confidence The document is identified by the RNS Number (2101H) and the date (30 July 2019), indicating it is a regulatory announcement from a UK-listed company (Synthomer PLC). The content explicitly discusses the 'Results of Rump Placing' following a '1 for 4 rights issue' and provides details on the allotment of 'New Synthomer Shares'. It also mentions the total voting rights and references a Prospectus published on 10 July 2019. This type of announcement, detailing the outcome of a capital-raising event (Rights Issue/Placing) and providing required regulatory updates (like total voting rights), is typically disseminated via the Regulatory News Service (RNS). Since it is an announcement about a corporate action and not the full financial report (10-K, IR) or a presentation (IP), the most appropriate classification is RNS, which serves as the general regulatory filing category for such market notices.
2019-07-30 English
Results of Rights Issue
Capital/Financing Update Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Synthomer PLC, dated July 30, 2019. The content explicitly details the 'Results of Rights Issue' related to the acquisition of OMNOVA Solutions Inc. It discusses acceptance rates, expected dealings, underwriting arrangements, and concludes with a 'Total Voting Rights' notification required under FCA Disclosure and Transparency Rules. While it relates to capital structure changes (Rights Issue), the primary function of this specific document, identified by the 'RNS Number' header and the nature of the announcement (reporting on a corporate action outcome), aligns best with a general regulatory announcement or a specific capital/financing update. Since it is a formal announcement disseminated via the RNS system detailing the outcome of a significant corporate action (Rights Issue), it fits the description of a Capital/Financing Update (CAP) or a general Regulatory Filing (RNS). Given the specific nature of the content (Rights Issue results and total voting rights update), CAP is highly relevant, but RNS is the designated category for general regulatory announcements disseminated via the RNS system that might not fit other specific codes perfectly, although CAP is very close. However, the document is a full announcement detailing the results of a capital raising event, which strongly points to 'Capital/Financing Update' (CAP). The document is substantial (over 24k characters) and contains the full details, not just a notice that a report is attached, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule if a more specific code exists. Since it is a detailed report on the results of a Rights Issue, CAP is the most precise fit among the options provided for corporate financing events.
2019-07-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.